Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Brichory

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Disease Markers|January 16, 2002
A proteomic approach to the identification of lung cancer markersS Hanash, F Brichory, D Beer
Bulletin Du Cancer|November 21, 2000
[Vertebrate galectins: structure and function, role in tumoral process]R Bassen, F Brichory, S Caulet-Maugendre, et al.
Cancer Research|November 3, 2001
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancerF Brichory, D Beer, F Le Naour, et al.
Proteomics|November 28, 2001
Protein based microarrays: a tool for probing the proteome of cancer cells and tissuesJ Madoz-Gúrpide, H Wang, D E Misek, et al.
International Journal of Molecular Medicine|August 9, 2001
Galectin-8: a complex sub-family of galectins (Review)N Bidon, F Brichory, P Bourguet, et al.
Anticancer Research|June 9, 2001
Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cellsN Bidon, F Brichory, D Thomas, et al.
British Journal of Cancer|November 1, 1995
Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicinB Desrues, H Léna, F Brichory, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicinB Desrues, F Brichory, H Léna, et al.
Gene|October 25, 2001
Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell lineN Bidon, F Brichory, S Hanash, et al.
Anticancer Research|March 4, 2000
Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissuesR Bassen, F Brichory, S Caulet-Maugendre, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Disease Markers|January 16, 2002
A proteomic approach to the identification of lung cancer markersS Hanash, F Brichory, D Beer
Bulletin Du Cancer|November 21, 2000
[Vertebrate galectins: structure and function, role in tumoral process]R Bassen, F Brichory, S Caulet-Maugendre, et al.
Cancer Research|November 3, 2001
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancerF Brichory, D Beer, F Le Naour, et al.
Proteomics|November 28, 2001
Protein based microarrays: a tool for probing the proteome of cancer cells and tissuesJ Madoz-Gúrpide, H Wang, D E Misek, et al.
International Journal of Molecular Medicine|August 9, 2001
Galectin-8: a complex sub-family of galectins (Review)N Bidon, F Brichory, P Bourguet, et al.
Anticancer Research|June 9, 2001
Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cellsN Bidon, F Brichory, D Thomas, et al.
British Journal of Cancer|November 1, 1995
Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicinB Desrues, H Léna, F Brichory, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicinB Desrues, F Brichory, H Léna, et al.
Gene|October 25, 2001
Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell lineN Bidon, F Brichory, S Hanash, et al.
Anticancer Research|March 4, 2000
Expression of Po66-CBP, a type-8 galectin, in different healthy, tumoral and peritumoral tissuesR Bassen, F Brichory, S Caulet-Maugendre, et al.
Pageof 2